Medical Cannabis Prescriber: A Guide to Rules and Practice

Find out what a medical cannabis prescriber needs to master in 2026: Anvisa rules, differences between CBD and THC, ethics, and prescription templates.

06/08/2026 06h00

Medical Cannabis Prescriber: A Guide to Rules and Practice — Doctor analyzing a bottle of medical cannabis oil and filling out a medical prescription at the consultation desk.

Python
import weasyprint

html_content = """<!DOCTYPE html>
<html lang="en-US">
<head>
<meta charset="UTF-8">
<style>
    @page {
        size: A4;
        margin: 18mm 16mm;
        background-color: #f8faf9;
    }
    
    *, *::before, *::after {
        box-sizing: border-box;
    }

    body {
        font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
        color: #2c3e35;
        line-height: 1.6;
        font-size: 10.5pt;
        margin: 0;
        padding: 0;
    }

    .header-banner {
        background-color: #1b4332;
        color: #ffffff;
        padding: 24px 20px;
        margin: -18mm -16mm 20px -16mm;
        border-bottom: 4px solid #40916c;
    }

    .category-tag {
        font-size: 8.5pt;
        text-transform: uppercase;
        letter-spacing: 1.5px;
        color: #74c69d;
        font-weight: bold;
        margin-bottom: 6px;
    }

    h1 {
        font-size: 18pt;
        line-height: 1.25;
        margin: 0 0 10px 0;
        font-weight: 700;
        color: #ffffff;
    }

    .meta-info {
        font-size: 8.5pt;
        color: #d8f3dc;
        border-top: 1px solid rgba(255, 255, 255, 0.2);
        padding-top: 8px;
        margin-top: 10px;
    }

    .summary-box {
        background-color: #e8f5e9;
        border-left: 4px solid #2d6a4f;
        padding: 12px 16px;
        margin-bottom: 20px;
        border-radius: 0 6px 6px 0;
    }

    .summary-box h3 {
        margin: 0 0 8px 0;
        font-size: 11pt;
        color: #1b4332;
        text-transform: uppercase;
        letter-spacing: 0.5px;
    }

    .summary-box ul {
        margin: 0;
        padding-left: 18px;
    }

    .summary-box li {
        margin-bottom: 4px;
        font-size: 9.5pt;
        color: #2d6a4f;
    }

    h2 {
        font-size: 13pt;
        color: #1b4332;
        border-left: 4px solid #52b788;
        padding-left: 10px;
        margin: 22px 0 12px 0;
        page-break-after: avoid;
    }

    p {
        margin: 0 0 12px 0;
        text-align: justify;
    }

    .internal-link-callout {
        background-color: #ffffff;
        border: 1px solid #b7e4c7;
        border-left: 4px solid #40916c;
        padding: 8px 12px;
        margin: 16px 0;
        font-weight: bold;
        font-size: 9.5pt;
        color: #1b4332;
        border-radius: 4px;
    }

    .internal-link-callout a {
        color: #2d6a4f;
        text-decoration: none;
    }

    .references {
        margin-top: 30px;
        padding-top: 12px;
        border-top: 1px solid #d3d3d3;
        font-size: 8.5pt;
        color: #555555;
    }

    .references h4 {
        margin: 0 0 6px 0;
        font-size: 9.5pt;
        color: #1b4332;
        text-transform: uppercase;
    }

    .references ul {
        margin: 0;
        padding-left: 16px;
    }

    .references li {
        margin-bottom: 4px;
    }

    a {
        color: #2d6a4f;
        text-decoration: underline;
    }
</style>
</head>
<body>

<div class="header-banner">
    <div class="category-tag">Health & Medical Regulation</div>
    <h1>Medical Cannabis Prescriber: A Guide to Rules and Practice</h1>
    <div class="meta-info">
        By Specialized Newsroom | Reviewed by Dr. Camila Ribeiro (Cannabis Medicine Specialist) | Updated in August 2026
    </div>
</div>

<p>Acting as a <strong>medical cannabis prescriber</strong> requires much more than just knowing the name of a product or following health market trends. Healthcare professionals need to thoroughly understand the patient's clinical condition, assess whether there has been a prior attempt with conventional treatments, and critically evaluate whether cannabinoid therapy can truly bring concrete benefits.</p>

<p>Indication must be strictly individualized, based on robust clinical criteria, a complete health history, assessment of potential drug interactions, and a clear definition of therapeutic goals. Recognizing the limits of therapy is fundamental, understanding that treatment response varies among individuals and that continuous monitoring is essential.</p>

<div class="summary-box">
    <h3>In this article you will see:</h3>
    <ul>
        <li>Rigorous clinical assessment and patient monitoring</li>
        <li>Regulatory aspects of Anvisa and professional council rules</li>
        <li>Veterinary use and current regulatory discussions</li>
        <li>Pharmacology of cannabinoids: crucial differences between CBD and THC</li>
        <li>Documentary requirements and prescription models in 2026</li>
    </ul>
</div>

<h2>Anvisa Rules and Legislation for the Medical Cannabis Prescriber</h2>

<p>Regulatory compliance is a vital pillar for legal and ethical safety in the practice of cannabis medicine. In Brazil, prescribing cannabis-based products is restricted to legally qualified professionals and must strictly follow the regulations established by the National Health Surveillance Agency (Anvisa) and the respective professional councils.</p>

<p>Currently, physicians and dental surgeons have the prerogative to prescribe cannabis products for human use, provided they are duly qualified and respect the boundaries of their professional practice, as detailed in the <a href="https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/cannabis/etapa1" target="_blank">official guidelines for controlled medications</a>.</p>

<div class="internal-link-callout">
    [LEARN MORE: <a href="#">How to structure the initial evaluation consultation for cannabinoid prescription</a>]
</div>

<p>In the field of veterinary medicine, the scenario is constantly evolving technically and normatively. There are active discussions and specific regulations underway, as indicated in the update on <a href="https://www.gov.br/anvisa/pt-br/setorregulado/regularizacao/medicamentos/fitoterapicos-dinamizados-e-especificos/informes/especificos/p-r-rdc-1015-2026_20072026.pdf" target="_blank">Anvisa's RDC 1015/2026</a>. Therefore, veterinary prescribers must always check current rules with their professional council before formalizing any recommendation.</p>

<h2>Pharmacology, CBD/THC Ratio, and Prescription Requirements</h2>

<p>Mastering the fundamental concepts of cannabinoid pharmacology is a mandatory requirement for safe clinical practice. Prescribers must understand the operational and therapeutic nuances between Cannabidiol (CBD) and Tetrahydrocannabinol (THC), as well as their potential applications and risk profiles associated with each formulation type.</p>

<p>Furthermore, it is essential to know how to interpret medical prescription rules, paying attention to THC concentration, product type, and established access pathway. These specificities determine the required documentation and the correct workflow for pharmacy dispensing or authorized importation.</p>

<div class="internal-link-callout">
    [LEARN MORE: <a href="#">Understand the difference between Type A, Type B, and Special Prescription Notification forms</a>]
</div>

<p>In practice, this requires prescribing with utmost clarity, transparently guiding the patient regarding expectations, and conducting regular follow-ups for dose titration, efficacy monitoring, and management of any adverse effects, as highlighted in materials on <a href="https://fgmed.org/blog/cannabis-medicinal-na-pratica-medica-prescricao-evidencias-e-regras-da-anvisa-em-2026/" target="_blank">medical cannabis in medical practice</a>.</p>

<h2>Conclusion: Ethics, Updating, and Medical Responsibility</h2>

<p>In summary, a good medical cannabis prescriber combines solid technical competence, ethical responsibility, and a commitment to continuous education. Knowing when to prescribe, how to instruct, which documents to issue, and how to conduct safe patient follow-up are the elements that ensure effective, humanized, and thoroughly reliable therapy.</p>

<div class="references">
    <h4>Sources and Bibliographic References</h4>
    <ul>
        <li>Agência Nacional de Vigilância Sanitária - Anvisa. <em>Regulatory Instructions and Steps for Cannabis Products</em>. Available at: <a href="https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/cannabis/etapa1">Anvisa Step 1</a>.</li>
        <li>Agência Nacional de Vigilância Sanitária - Anvisa. <em>Technical Report on Regulatory Updates and RDC 1015/2026</em>. Available at: <a href="https://www.gov.br/anvisa/pt-br/setorregulado/regularizacao/medicamentos/fitoterapicos-dinamizados-e-especificos/informes/especificos/p-r-rdc-1015-2026_20072026.pdf">RDC Document 1015/2026</a>.</li>
        <li>FGMed. <em>Medical Cannabis in Medical Practice: Prescription, Evidence, and Rules in 2026</em>. Available at: <a href="https://fgmed.org/blog/cannabis-medicinal-na-pratica-medica-prescricao-evidencias-e-regras-da-anvisa-em-2026/">FGMed Blog</a>.</li>
    </ul>
</div>

</body>
</html>
"""

with open("noticia_prescritor_cannabis_seo.html", "w", encoding="utf-8") as f:
    f.write(html_content)

weasyprint.HTML("noticia_prescritor_cannabis_seo.html").write_pdf("noticia_prescritor_cannabis_seo.pdf")
print("PDF generated successfully!")

Code output
PDF generated successfully!

Acting as a medical cannabis prescriber requires much more than just knowing the name of a product or following health market trends. Healthcare professionals need to thoroughly understand the patient's clinical condition, assess whether there has been a prior attempt with conventional treatments, and critically evaluate whether cannabinoid therapy can truly bring concrete benefits.

Indication must be strictly individualized, based on robust clinical criteria, a complete health history, assessment of potential drug interactions, and a clear definition of therapeutic goals. Recognizing the limits of therapy is fundamental, understanding that treatment response varies among individuals and that continuous monitoring is essential.

In this article you will see:

Rigorous clinical assessment and patient monitoring
Regulatory aspects of Anvisa and professional council rules
Veterinary use and current regulatory discussions
Pharmacology of cannabinoids: crucial differences between CBD and THC
Documentary requirements and prescription models in 2026

Anvisa Rules and Legislation for the Medical Cannabis Prescriber

Regulatory compliance is a vital pillar for legal and ethical safety in the practice of cannabis medicine. In Brazil, prescribing cannabis-based products is restricted to legally qualified professionals and must strictly follow the regulations established by the National Health Surveillance Agency (Anvisa) and the respective professional councils.

Currently, physicians and dental surgeons have the prerogative to prescribe cannabis products for human use, provided they are duly qualified and respect the boundaries of their professional practice, as detailed in the official guidelines for controlled medications.

[LEARN MORE: How to structure the initial evaluation consultation for cannabinoid prescription]

In the field of veterinary medicine, the scenario is constantly evolving technically and normatively. There are active discussions and specific regulations underway, as indicated in the update on Anvisa's RDC 1015/2026. Therefore, veterinary prescribers must always check current rules with their professional council before formalizing any recommendation.

Pharmacology, CBD/THC Ratio, and Prescription Requirements

Mastering the fundamental concepts of pharmacology of cannabinoids is a mandatory requirement for safe clinical practice. Prescribers must understand the operational and therapeutic nuances between Cannabidiol (CBD) and Tetrahydrocannabinol (THC), as well as their potential applications and risk profiles associated with each formulation type.

Furthermore, it is essential to know how to interpret medical prescription rules, paying attention to THC concentration, product type, and established access pathway. These specificities determine the required documentation and the correct workflow for pharmacy dispensing or authorized importation.

[LEARN MORE: Understand the difference between Type A, Type B, and Special Prescription Notification forms]

In practice, this requires prescribing with utmost clarity, transparently guiding the patient regarding expectations, and conducting regular follow-ups for dose titration, efficacy monitoring, and management of any adverse effects, as highlighted in materials on medical cannabis in medical practice.

Conclusion: Ethics, Updating, and Medical Responsibility

In summary, a good medical cannabis prescriber combines solid technical competence, ethical responsibility, and a commitment to continuous education. Knowing when to prescribe, how to instruct, which documents to issue, and how to conduct safe patient follow-up are the elements that ensure effective, humanized, and thoroughly reliable therapy.

Sources and Bibliographic References on medical cannabis prescriber

Agência Nacional de Vigilância Sanitária (Anvisa). Regulatory Instructions and Steps for Cannabis Products. Available at: gov.br/anvisa/etapa1..Anvisa
Agência Nacional de Vigilância Sanitária (Anvisa). Technical Report on RDC 1015/2026. Available at: gov.br/anvisa/rdc-1015-2026.Gov.br
FGMed. Medical Cannabis in Medical Practice: Prescription, Evidence, and Rules in 2026. Available at: fgmed.org/blog.EMec

Reviewed by Sechat Editorial Staff - content explains medical cannabis prescribing